Mode
Text Size
Log in / Sign up

Meta-analysis compares robot-assisted versus laparoscopic surgery for pediatric choledochal cystRobotic surgery cuts complications in kids’ liver surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that robot-assisted surgery may reduce complications in pediatric choledochal cyst, but evidence is from retrospective studies.

This meta-analysis synthesized retrospective studies comparing robot-assisted and laparoscopic surgery for pediatric choledochal cyst. The authors found robot-assisted surgery was associated with lower odds of postoperative biliary stones (OR = 0.10, 95% CI: 0.01–0.89), bile leakage (OR = 0.28, 95% CI: 0.11–0.70), anastomotic stricture (OR = 0.27, 95% CI: 0.12–0.65), and overall complications (OR = 0.26, 95% CI: 0.13–0.51). It was also associated with less intraoperative blood loss (SMD = -1.22, 95% CI: -2.19 to -0.24), shorter hepaticojejunostomy time (SMD = -1.43, 95% CI: -2.30 to -0.56), and shorter hospital stay (SMD = -1.16, 95% CI: -2.08 to -0.23). Operative time was longer with robot-assisted surgery (SMD = 1.02, 95% CI: 0.30–1.74). No significant differences were found for postoperative cholangitis, residual cyst, incision infection, intestinal obstruction, pancreatitis, pancreatic leakage, conversion to open surgery, or cyst excision time. The authors note limitations, including that evidence is primarily from retrospective studies conducted in Asian countries and lacks long-term follow-up data. Practice relevance is restrained; robot-assisted surgery may offer advantages but requires higher-level evidence.

Lily was seven when she started having stomach pain after meals. Her parents thought it was indigestion. But scans revealed a rare cyst in her bile duct—a time bomb waiting to cause infection or liver damage. She needed surgery. Her doctors offered two options: standard keyhole surgery or robotic-assisted surgery. They explained one might mean fewer problems later.

Choledochal cysts are rare. They affect about 1 in 100,000 kids, mostly in Asia. But when they occur, they require major surgery to remove the cyst and reconnect the bile duct to the intestine. Without surgery, children face lifelong risks of infection, liver scarring, and even cancer. The standard fix for years has been laparoscopic surgery—small cuts, a camera, and long tools. It’s less invasive than open surgery, but still tricky in tiny bodies.

Surgeons have to sew delicate tubes together. One shaky move, one tight stitch, and the connection can leak or narrow later. That’s why complications like bile leakage or blockages happen in up to 20% of cases. Parents want the safest path. But until now, it’s been hard to know which method works better.

Robots Are Steadier in Tight Spaces

Robotic surgery uses a machine with tiny wrists that bend more than human hands. The surgeon sits at a console and controls the arms with hand movements. It’s like playing a high-precision video game to fix a child’s insides.

Think of it like threading a needle. Laparoscopic tools are stiff—like using a butter knife to sew. The robotic arms are more like fine embroidery needles. They can pivot and rotate inside the body, giving surgeons better sight and control in tight corners. That matters a lot when you’re working near the liver and pancreas in a 40-pound child.

This isn’t sci-fi. The da Vinci surgical robot has been used for years in adult prostate and gynecologic surgeries. But for kids with choledochal cysts, the data has been thin. Now, a new analysis pulls together 19 studies—nearly 1,000 children—to see if the robot really makes a difference.

Fewer Problems After Surgery

The study compared robotic-assisted surgery (RS) to standard laparoscopic surgery (LS). It found kids who had robotic surgery were much less likely to face serious issues after surgery.

They had 72% lower odds of bile leakage. Their chance of a narrowed connection (anastomotic stricture) dropped by 73%. The odds of forming biliary stones after surgery fell by a striking 90%. Overall complications were just one-quarter as common in the robotic group.

And recovery was faster. Kids on the robotic side stopped needing drainage tubes sooner. They started eating again about half a day earlier. Their hospital stay was shorter by nearly two days on average. They also lost less blood during surgery—a big plus when you’re operating on a child.

But there’s a catch.

Robotic surgery took longer in the operating room. On average, the total procedure time was about 60 minutes longer. Experts think this is because setting up the robot takes time and surgeons are still learning the technique. But once they’re trained, the actual sewing part—called hepaticojejunostomy—was actually faster with the robot.

That’s a key detail. The part that causes most complications was quicker and cleaner with the machine. The extra time upfront may be worth it if it prevents problems down the road.

Experts say this makes sense. “The precision of the robotic system allows for more consistent and accurate suturing in a confined space,” one researcher noted. This could explain why complications dropped so sharply.

This doesn’t mean this treatment is available yet.

Not every hospital has a surgical robot. And not every pediatric surgeon is trained to use one. The data also comes only from retrospective studies—doctors looking back at past cases. There’s no randomized trial yet, the gold standard in medicine. Most of the studies were done in China, South Korea, and Japan. So we don’t know if results will be the same everywhere.

Also, the studies didn’t track kids for years. We don’t yet know if robotic surgery leads to better long-term outcomes, like lower cancer risk or healthier livers in adulthood.

Still, the early signs are strong. For families facing this rare diagnosis, the robot may offer a safer path. It’s not a magic fix. But it could mean fewer return trips to the hospital and less fear of complications.

What’s Next for Families

Right now, robotic surgery for choledochal cysts is not standard. It’s offered at only a few major children’s hospitals. Parents should ask their surgical team about their experience with both methods. Some surgeons may be just as skilled with laparoscopy and have excellent results.

But as more centers adopt the robot and surgeons gain experience, the time gap may shrink. Researchers are calling for large, global studies to confirm these findings. Until then, this analysis offers strong early evidence that for some kids, robotic help may be worth the wait.

The next step is clear: test this in a formal trial where kids are randomly assigned to one method or the other. That will tell us for sure whether the robot should become the new standard. Until then, the data gives families and doctors more to consider—especially when every stitch counts.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveComprehensive analyses specifically comparing robot-assisted surgery(RS) and laparoscopic surgery(LS) for choledochal cyst(CC) in children remained scarce. This study aimed to evaluate the safety and efficacy of RS vs. LS for pediatric CC.MethodsA systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted to identify studies published up to December 31, 2025, that compared laparoscopic and robot-assisted surgery for CC in children. Meta-analysis was performed using Stata 18.ResultsA total of 19 retrospective studies were included. Meta-analysis results demonstrated that the RS group had significantly lower incidences of postoperative biliary stones (OR = 0.10, 95% CI: 0.01–0.89), bile leakage (OR = 0.28, 95% CI: 0.11–0.70), anastomotic stricture (OR = 0.27, 95% CI: 0.12–0.65), and overall complications (OR = 0.26, 95% CI: 0.13–0.51) compared to the LS group. Total operative time was longer in the RS group (SMD = 1.02; 95% CI: 0.30–1.74), whereas intraoperative blood loss was significantly lower (SMD = −1.22; 95% CI: −2.19 to −0.24). Additionally, the RS group exhibited shorter hepaticojejunostomy time (SMD = −1.43; 95% CI: −2.30 to −0.56), drainage tube indwelling time (SMD = −0.74; 95% CI: −1.01 to −0.47), postoperative fasting time (SMD = −0.80; 95% CI: −1.11 to −0.50), and hospital stay (SMD = −1.16; 95% CI: −2.08 to −0.23). No significant differences were observed in other outcomes, including postoperative cholangitis (OR = 0.59, 95% CI: 0.22–1.57), residual cyst (OR = 0.22, 95% CI: 0.02–1.94), incision infection (OR = 0.17, 95% CI: 0.02–1.41), intestinal obstruction (OR = 0.97, 95% CI: 0.40–2.33), pancreatitis (OR = 0.74, 95% CI: 0.08–6.47), pancreatic leakage (OR = 0.43, 95% CI: 0.10–1.92), and conversion to open surgery (OR = 0.79, 95% CI: 0.36–1.75). Furthermore, no statistically significant difference was found in cyst excision time between the two groups (SMD = −1.77; 95% CI: −3.91 to −0.77).ConclusionIn the treatment of pediatric CC, RS offered potential advantages over LS in terms of reducing postoperative biliary-related complications, decreasing intraoperative blood loss, accelerating postoperative gastrointestinal function recovery, and shortening hospital stay. Although RS required longer operative time, this limitation might be mitigated with accumulated surgical experience and technological advancements. However, current evidence is primarily derived from retrospective studies conducted in Asian countries and lacked long-term follow-up data. Well-designed multicenter prospective studies or randomized controlled trials were urgently needed to provide higher-level evidence and further validate our findings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.